APOH and autoimmune polyendocrinopathy: It is widely accepted that anti-β2GPI antibodies play a pathogenic role in APS and have been shown to induce activation of ECs, in vitro and in vivo, which may contribute to hypercoagulability in APS patients [12, 25–26].